At a glance
- Originator Takeda
- Class Eye disorder therapies; Vitamins
- Mechanism of Action Free radical scavengers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders
Most Recent Events
- 04 Nov 1998 Discontinued-III for Ischaemic heart disorders in Japan (Unknown route)